ATHENS, Ohio--(BUSINESS WIRE)--Diagnostic HYBRIDS announces the release of its D3® Ultra 8TM DFA Respiratory Virus Screening & Identification Kit for the Canadian market. Ultra 8 is the only commercially available monoclonal antibody blend that detects and identifies eight major respiratory viruses - including human metapneumovirus - in direct patient specimens and cell culture by immunofluorescence. Direct specimen results are available in as little as 15-30 minutes. When combined with the patented Diagnostic HYBRIDS cell culture systems (R-MixTM and R-Mix TooTM Mixed FreshCellsTM), multi-virus results can be obtained in as little as 24 hours for influenza A and B, and less than 48 hours for MPV, RSV, Adenovirus, and Parainfluenza 1, 2, and 3.
